IDev Technologies’ SUPERA interwoven nitinol self-expanding stent is designed for palliative treatment of malignant ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
September 11, 2008
September 11, 2008 -Cook Medical has completed enrollment in the first international clinical trial of a first-of ...
September 10, 2008The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.
Boston Scientific ...
September 09, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023September 5, 2008 - The results of the SYNTAX study, a head-to-head comparison between drug-eluting stents (DES) using ...
September 04, 2008Feature | Venkat Rajan, medical research analyst, Frost & Sullivan
This comparison chart features three categories of stents: coronary, carotid and peripheral. We gratefully acknowledge ...
September 03, 2008The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s ...
September 03, 2008September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
September 02, 2008September 2, 2008 – Boston Scientific Corp. today announced positive one-year results from the European and ...
September 01, 2008September 2, 2008 - Data from the landmark SYNTAX trial indicates patients with very complex coronary artery disease can ...
September 01, 2008September 2, 2008 - Patients with both diabetes and advanced blockages in at least three heart vessels will find good ...
September 01, 2008August 29, 2008 - The Vascular Medtronic Talent Thoracic Stent Graft System (VALOR) is a safe and effective endovascular ...
August 28, 2008August 28, 2008 – In patients with diabetes, the CYPHER Sirolimus-eluting coronary stent outperformed the Taxus stent ...
August 27, 2008Stentys, a French-based company, will feature its bifurcated stent at TCT 2008.
The patent-pending bifurcated stent is ...
August 26, 2008August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus ...
August 26, 2008Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the ...
August 25, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now